Difference between revisions of "Vibrio cholerae"

From QMRAwiki
Jump to: navigation, search
m (Case fatality ratio)
(Recommended Dose Response Model)
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
=='''''Vibrio cholerae''''' (Cholera)==
+
=Hosts=
 
 
 
 
===Hosts===
 
 
Humans
 
Humans
  
===Transmission/Exposure Routes===
+
=Transmission/Exposure Routes=
Fecal-oral transmission ([http://emedicine.medscape.com/article/962643-overview#showall Medscape])
+
Fecal-oral transmission <ref name=Medscape>[http://emedicine.medscape.com/article/962643-overview#showall Medscape]</ref>
  
===Incubation Times===
+
=Incubation Times=
 
Four hours to five days with an average of 2-3 days <ref name=AZDHS>[http://www.azdhs.gov/phs/edc/edrp/es/profcholera.htm Arizona Department of Health Services Cholera Page]</ref>
 
Four hours to five days with an average of 2-3 days <ref name=AZDHS>[http://www.azdhs.gov/phs/edc/edrp/es/profcholera.htm Arizona Department of Health Services Cholera Page]</ref>
  
===Case Fatality Ratios===
+
 
===Case fatality ratio ===
+
=Case fatality ratio =
 
{|                                                   
 
{|                                                   
 
{| border = "1"
 
{| border = "1"
Line 53: Line 50:
 
|}
 
|}
  
===Burden of Disease===
+
=Burden of Disease=
 
The incidence of Vibrio infection in the United States continues to be low, with highest number documented in the age group older than 50 years, which has been around 0.50 cases per 100,000 population from 2003-2008. The frequency of cholera among international travelers returning to the United States has averaged 1 case per 500,000 population, with a range of 0.05-3.7 cases per 100,000 population, depending on the countries visited. ([http://emedicine.medscape.com/article/962643-overview#showall Medscape])   
 
The incidence of Vibrio infection in the United States continues to be low, with highest number documented in the age group older than 50 years, which has been around 0.50 cases per 100,000 population from 2003-2008. The frequency of cholera among international travelers returning to the United States has averaged 1 case per 500,000 population, with a range of 0.05-3.7 cases per 100,000 population, depending on the countries visited. ([http://emedicine.medscape.com/article/962643-overview#showall Medscape])   
 
====Duration of Infectiousness and disease====
 
====Duration of Infectiousness and disease====
Line 63: Line 60:
 
====Excretion Rates  (see Exposure) ====
 
====Excretion Rates  (see Exposure) ====
 
====Immunity====
 
====Immunity====
Injectable, killed WC cholera vaccines date back to the nineteenth century, but fell in popularity due to unfavorable safety levels and low levels of effectiveness.  Oral vaccines are now the preferred method of vaccination because they serve as an efficient method of eliciting the primary intestinal mucosal immune responses.  There are two major oral vaccines; killed whole cell (WC)-based and genetically attenuated live vaccines. ([http://cid.oxfordjournals.org/content/52/11/1343.long S. Plotkin])
+
Injectable, killed WC cholera vaccines date back to the nineteenth century, but fell in popularity due to unfavorable safety levels and low levels of effectiveness.  Oral vaccines are now the preferred method of vaccination because they serve as an efficient method of eliciting the primary intestinal mucosal immune responses.  There are two major oral vaccines; killed whole cell (WC)-based and genetically attenuated live vaccines. ([http://cid.oxfordjournals.org/content/52/11/1343.long S. Plotkin])Killed WC variants of the vaccine that contain both ''Vibrio cholerae'' O1 and O139 provides 50% protection for 3 years. ([http://www.landesbioscience.com.proxy1.cl.msu.edu/journals/vaccines/article/19083/?nocache=1608705454 Verma, Khanna, and Chawla])
  
===Microbiology===
+
=Microbiology=
 
A comma-shaped, gram-negative aerobic or facultatively anaerobic bacillus that varies in size from 1-3 µm in length by 0.5-0.8 µm in diameter ([http://emedicine.medscape.com/article/962643-overview#showall Medscape])
 
A comma-shaped, gram-negative aerobic or facultatively anaerobic bacillus that varies in size from 1-3 µm in length by 0.5-0.8 µm in diameter ([http://emedicine.medscape.com/article/962643-overview#showall Medscape])
  
===Recommended Dose Response Model===
+
=Environmental Survival=
[[has DR model::Dose response models for Vibrio cholera]] <br /> Beta-Poisson, α is 0.250, N<sub>50</sub> is 243 <br /> [[File:Betapoisson_model.jpg|thumb|left|300px]]
 
 
 
 
 
 
 
 
 
  
 +
=Recommended Dose Response Model=
 +
[[Vibrio cholerae: Dose Response Models]] <br /> Beta-Poisson, α is 0.250, N<sub>50</sub> is 243 <br /> [[File:Betapoisson_model.jpg|thumb|left|300px]]<br /><br /><br /><br />
  
  
 +
<headertabs />
  
 
===References===
 
===References===
Line 82: Line 77:
 
[http://emedicine.medscape.com/article/962643-overview#showall Medscape Page] <br />
 
[http://emedicine.medscape.com/article/962643-overview#showall Medscape Page] <br />
 
[http://cid.oxfordjournals.org/content/52/11/1343.long S. Plotkin] <br />
 
[http://cid.oxfordjournals.org/content/52/11/1343.long S. Plotkin] <br />
 +
[http://www.landesbioscience.com.proxy1.cl.msu.edu/journals/vaccines/article/19083/?nocache=1608705454 Verma, Khanna, Chawla] <br/>
 
<references />
 
<references />
  
  
[[Category:PSDS]][[Category:Bacterium]]
+
 
 +
[[Category:Agent Overview]][[Category:Bacterium]]

Latest revision as of 20:23, 15 October 2012

[edit]

Humans

Fecal-oral transmission [1]

Four hours to five days with an average of 2-3 days [2]


Case fatality ratios
Case Fatality Ratio Conditions Population References
>50% Before Fluid Replenishment Care General Medscape
1% To Date General US and European populations Medscape
<1% Patients with Severe Dehydration Bangladesh, Treatment Center of the International Center for Diarrheal Disease Research Medscape
4% Data Collected in 1999 Africa Medscape
30-50% Severe infection without treatment Global Verma, Khanna, and Chawla
2.3% (4,031 of 177,963) None Worldwide Verma,Khanna, and Chawla

The incidence of Vibrio infection in the United States continues to be low, with highest number documented in the age group older than 50 years, which has been around 0.50 cases per 100,000 population from 2003-2008. The frequency of cholera among international travelers returning to the United States has averaged 1 case per 500,000 population, with a range of 0.05-3.7 cases per 100,000 population, depending on the countries visited. (Medscape)

Duration of Infectiousness and disease

Symptomology

Very often, there are no symptoms associated with Cholera. However, more severe cases may be characterized by watery diarrhea, vomiting, and leg cramps. Individuals can become extremely dehydrated which can cause shock. In extreme cases, death can occur within hours. [3]

Latency

Asymptomatic Rates

Excretion Rates (see Exposure)

Immunity

Injectable, killed WC cholera vaccines date back to the nineteenth century, but fell in popularity due to unfavorable safety levels and low levels of effectiveness. Oral vaccines are now the preferred method of vaccination because they serve as an efficient method of eliciting the primary intestinal mucosal immune responses. There are two major oral vaccines; killed whole cell (WC)-based and genetically attenuated live vaccines. (S. Plotkin)Killed WC variants of the vaccine that contain both Vibrio cholerae O1 and O139 provides 50% protection for 3 years. (Verma, Khanna, and Chawla)

A comma-shaped, gram-negative aerobic or facultatively anaerobic bacillus that varies in size from 1-3 µm in length by 0.5-0.8 µm in diameter (Medscape)

References

CDC Cholera Page
Medscape Page
S. Plotkin
Verma, Khanna, Chawla

  1. Medscape
  2. Arizona Department of Health Services Cholera Page
  3. CDC http://www.cdc.gov/cholera/general/#symptoms